Journal of Alzheimer's Disease

Top Research Topics at Journal of Alzheimer's Disease?

Journal of Alzheimer's Disease focuses on Disease, Dementia, Internal medicine, Cognition and Neuroscience. Some problems in Disease that were presented in Journal of Alzheimer's Disease overlapped with concepts under Biomarker (medicine) and Immunology. Journal of Alzheimer's Disease facilitates discussions on Dementia that incorporate concepts from other fields like Psychiatry, Clinical psychology, Gerontology and Cohort.

Journal of Alzheimer's Disease explores issues in Internal medicine which can be linked to other research areas like Endocrinology, Oncology and Cardiology. Oxidative stress is a major topic of Endocrinology research presented in it. Cognition study tackled is connected to the field of Audiology.

The journal connects research in Neuroscience with the related topic of Neurodegeneration. The Pathology study tackling the subject of Amyloid is the focus of the journal. The studies tackled, which mainly focus on Hippocampus, apply to Hippocampal formation as well.

• Disease (32.54%)
• Dementia (31.44%)
• Internal medicine (29.50%)

What are the most cited papers published in the journal?

• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? (1166 citations)
• Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways (743 citations)
• Alzheimer's Disease and the Amyloid-β Peptide (719 citations)

Research areas of the most cited articles at Journal of Alzheimer's Disease:

The most cited articles focus largely on the fields of Disease, Internal medicine, Dementia, Neuroscience and Alzheimer's disease. The Disease research tackled in the most cited articles is interrelated with Oxidative stress which concerns subjects like Mitochondrion. The Internal medicine research presented in the most cited papers focuses mostly on Endocrinology and, on occasion, topics in Genetically modified mouse.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Disease

The previous edition focused in particular on these issues:

The primary areas of discussion in the journal are Dementia, Disease, Cognition, Internal medicine and Cognitive decline. While it focused on Dementia, it was also able to explore topics like Cohort study, Gerontology, Cohort, Cognitive impairment and Depression (differential diagnoses). It addresses concerns in Disease which are intertwined with other disciplines, such as Biomarker (medicine) and Neuroimaging, Neuroscience.

It focuses on Cognition but the discussions also offer insight into other areas such as Clinical psychology and Audiology. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Endocrinology, Oncology and Cardiology. The in-depth study on Cognitive decline also explores topics in the intersecting field of Demography.

The most cited articles from the last journal are:

• Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline. (15 citations)
• The Latin America and the Caribbean Consortium on Dementia (LAC-CD): From Networking to Research to Implementation Science. (11 citations)
• Is the Frontal Lobe the Primary Target of SARS-CoV-2? (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Journal of Alzheimer's Disease (based on the number of publications) are:

• Kaj Blennow (115 papers) published 8 papers at the last edition, 5 less than at the previous edition,
• Henrik Zetterberg (110 papers) published 9 papers at the last edition, 6 less than at the previous edition,
• Ralph N. Martins (80 papers) published 4 papers at the last edition, 6 less than at the previous edition,
• Alzheimer’s Disease Neuroimaging Initiative (78 papers) published 20 papers at the last edition, 2 less than at the previous edition,
• Hilkka Soininen (74 papers) published 2 papers at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Alzheimer's Disease (based on the number of publications) are:

• Karolinska Institutet (238 papers) published 22 papers at the last edition, 3 more than at the previous edition,
• Veterans Health Administration (175 papers) published 17 papers at the last edition, 2 less than at the previous edition,
• Harvard University (170 papers) published 20 papers at the last edition, 2 less than at the previous edition,
• National Institutes of Health (156 papers) published 8 papers at the last edition, 8 less than at the previous edition,
• French Institute of Health and Medical Research (154 papers) published 7 papers at the last edition, 6 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.75% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 14.01% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.21% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.35% of all publications and 59.44% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Contributions of Speech and Language Pathologists to Alzheimer's Research

A crucial part of mitigating the effects of Alzheimer's Disease and other forms of Dementia is through the study and practice of Speech and Language Pathology. This complex, yet rewarding professional field requires intensive study and licensure. In locations like Montana, prospective speech-language pathologists (SLPs) may have additional state-specific requirements that need to be addressed prior to being able to practice.

SLPs work diligently to build communication strategies for individuals with Alzheimer's Disease. They aid in addressing issues like cognitive-communication disorders, language impairment and swallowing difficulties, problems frequently encountered by those suffering from Alzheimer's disease. The interventions and strategies employed by these healthcare professionals have been proven to improve the overall quality of life for their patients.

Researchers in the field of Alzheimer's Disease should explore the contributions and academic insights provided by SLPs. Many SLPs engage in research that delves into the areas of Disease, Dementia, Internal medicine, Cognition, and Neuroscience, making their knowledge and perspectives of utmost value. Concurrently, aspiring SLPs are encouraged to contribute to the body of knowledge surrounding Alzheimer's Disease, as their novel insights and clinical expertise can aid in furthering our collective understanding of this disease.

Those interested in further sharpening their professional competence, or considering a career shift into this significant sector, can find more information about this rewarding and essential profession and the specific demands in their locale, for instance, the montana slp license requirements, on our dedicated page.